Evaluation of efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneratio
Not Applicable
- Conditions
- exudative age-related macular degeneration
- Registration Number
- JPRN-UMIN000002854
- Lead Sponsor
- Department of Ophthalmology, Osaka University Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
choroidal neovascularization secondary to pathorogical myopia or other diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method total number of injections of ranibizumab during 6 months' follow-up
- Secondary Outcome Measures
Name Time Method the rate of eyes with persistent leakage from choroidal neovascularization on fluorescein angiography